Prescribing Longevity

Dr Oliver Zolman makes the case for longevity companies to adopt a check list when it comes to making anti-aging claims.

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Oliver Zolman

Director, 20one Consulting Ltd

Prescribing Longevity


 

Phil Newman

Editor-in-Chief

Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

This field is hidden when viewing the form
Moonwalk raises $70m for adipose-targeted RNAi

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form